Phase 1 trial by Palatin for obesity treatment
A phase 1, single-blind, randomized, placebo-controlled trial started by Palatin Technologies is aimed at evaluating the efficiency of AZD282 for
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine